BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9624006)

  • 1. Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth.
    Schreiber-Agus N; Meng Y; Hoang T; Hou H; Chen K; Greenberg R; Cordon-Cardo C; Lee HW; DePinho RA
    Nature; 1998 Jun; 393(6684):483-7. PubMed ID: 9624006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repression by the Mad(Mxi1)-Sin3 complex.
    Schreiber-Agus N; DePinho RA
    Bioessays; 1998 Oct; 20(10):808-18. PubMed ID: 9819568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MXI1 tumor suppressor gene is not mutated in primary prostate cancer.
    Kuczyk MA; Serth J; Bokemeyer C; Schwede J; Herrmann R; Machtens S; Grünewald V; Höfner K; Jonas U
    Oncol Rep; 1998; 5(1):213-6. PubMed ID: 9458379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping of two genes encoding members of a distinct subfamily of MAX interacting proteins: MAD to human chromosome 2 and mouse chromosome 6, and MXI1 to human chromosome 10 and mouse chromosome 19.
    Edelhoff S; Ayer DE; Zervos AS; Steingrímsson E; Jenkins NA; Copeland NG; Eisenman RN; Brent R; Disteche CM
    Oncogene; 1994 Feb; 9(2):665-8. PubMed ID: 8290278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assignment of the human MAD and MXI1 genes to chromosomes 2p12-p13 and 10q24-q25.
    Shapiro DN; Valentine V; Eagle L; Yin X; Morris SW; Prochownik EV
    Genomics; 1994 Sep; 23(1):282-5. PubMed ID: 7829091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mxi1, a Myc antagonist, suppresses proliferation of DU145 human prostate cells.
    Taj MM; Tawil RJ; Engstrom LD; Zeng Z; Hwang C; Sanda MG; Wechsler DS
    Prostate; 2001 May; 47(3):194-204. PubMed ID: 11351349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MXI1, a putative tumor suppressor gene, suppresses growth of human glioblastoma cells.
    Wechsler DS; Shelly CA; Petroff CA; Dang CV
    Cancer Res; 1997 Nov; 57(21):4905-12. PubMed ID: 9354456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commonly occurring loss and mutation of the MXI1 gene in prostate cancer.
    Prochownik EV; Eagle Grove L; Deubler D; Zhu XL; Stephenson RA; Rohr LR; Yin X; Brothman AR
    Genes Chromosomes Cancer; 1998 Aug; 22(4):295-304. PubMed ID: 9669667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of the MXI1 gene in prostate cancer.
    Eagle LR; Yin X; Brothman AR; Williams BJ; Atkin NB; Prochownik EV
    Nat Genet; 1995 Mar; 9(3):249-55. PubMed ID: 7773287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mxi1-SRalpha: a novel Mxi1 isoform with enhanced transcriptional repression potential.
    Dugast-Darzacq C; Pirity M; Blanck JK; Scherl A; Schreiber-Agus N
    Oncogene; 2004 Nov; 23(55):8887-99. PubMed ID: 15467743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of myc-max-mad gene expression during hepatocyte proliferation in vivo: Differential regulation of mad family and stress-mediated induction of c-myc.
    Mauleon I; Lombard MN; Muñoz-Alonso MJ; Cañelles M; Leon J
    Mol Carcinog; 2004 Feb; 39(2):85-90. PubMed ID: 14750213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1.
    Lahoz EG; Xu L; Schreiber-Agus N; DePinho RA
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5503-7. PubMed ID: 8202517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mxi1 isoforms are expressed in hematological cell lines and normal bone marrow.
    Kawamata N; Sugimoto KJ; Sakajiri S; Oshimi K; Koeffler HP
    Int J Oncol; 2005 May; 26(5):1369-75. PubMed ID: 15809730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of Mxi1-SRalpha and Mxi1-SRbeta in Myc antagonism.
    Dugast-Darzacq C; Grange T; Schreiber-Agus NB
    FEBS J; 2007 Sep; 274(17):4643-53. PubMed ID: 17697116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIF-1alpha induces MXI1 by alternate promoter usage in human neuroblastoma cells.
    Löfstedt T; Fredlund E; Noguera R; Navarro S; Holmquist-Mengelbier L; Beckman S; Påhlman S; Axelson H
    Exp Cell Res; 2009 Jul; 315(11):1924-36. PubMed ID: 19254710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Max interacting protein 1: loss of heterozygosity is frequent in desmoplastic melanoma.
    Rao UN; Bakker A; Swalsky PA; Finkelstein SD
    Mod Pathol; 1999 Apr; 12(4):344-50. PubMed ID: 10229497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene-target recognition among members of the myc superfamily and implications for oncogenesis.
    O'Hagan RC; Schreiber-Agus N; Chen K; David G; Engelman JA; Schwab R; Alland L; Thomson C; Ronning DR; Sacchettini JC; Meltzer P; DePinho RA
    Nat Genet; 2000 Feb; 24(2):113-9. PubMed ID: 10655054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoregulation of the N-myc gene is operative in neuroblastoma and involves histone deacetylase 2.
    Kim MK; Carroll WL
    Cancer; 2004 Nov; 101(9):2106-15. PubMed ID: 15382088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mxi1 regulates cell proliferation through insulin-like growth factor binding protein-3.
    Ko JY; Yoo KH; Lee HW; Park JH
    Biochem Biophys Res Commun; 2011 Nov; 415(1):36-41. PubMed ID: 22008548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
    Choe C; Chen N; Sawadogo M
    Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.